Sandra Silberman

13.5k citations
38 papers · 6.8k · 4 hit papers · h-index 15

Impact in

Papers in

    • Cancer Treatment and Pharmacology 8
    • Chronic Myeloid Leukemia Treatments 8
    • Acute Myeloid Leukemia Research 5

Sandra Silberman

36 papers receiving 6.6k citations

Sandra Silberman's Hit Papers

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor 2003 · 1.7k citations
1.7k0+8+16Years since publication50010001.5k

Peers

Sandra Silberman
Comparison fields: 5 of 109
  • Gastroenterology 3.5k
  • Pulmonary and Respiratory Medicine 4.0k
  • Hematology 1.1k
  • Oncology 1.8k
  • Genetics 668
Replace Saša Dimitrijević with:
Saša Dimitrijević United States
Ajia Town United States
A. van Oosterom Belgium
Jonathan C. Trent United States
Maria Dêbiec‐Rychter Belgium
Herlinde Dumez Belgium
Scott M. Schuetze United States
Agnieszka Woźniak Belgium
Vivien Bramwell Canada
Philippe A. Cassier France
Sandra Silberman relative to Saša Dimitrijević United States Saša Dimitrijević's profile →
Citations per field
00.5×1.5×
Saša Dimitrijević · 1×
Citations per year

Countries citing papers authored by Sandra Silberman

Since Specialization
Citations

This map shows the geographic impact of Sandra Silberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Silberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Silberman more than expected).

Fields of papers citing papers by Sandra Silberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Silberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Silberman. The network helps show where Sandra Silberman may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandra Silberman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandra Silberman Line = papers co-authored together Sandra Silberman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Hit paper breakdown →
20031719
2
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
Hit paper breakdown →
20011525
3
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
Hit paper breakdown →
2001975
4
Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies
Hit paper breakdown →
2001830
5 2002452
6 2002449
7 2003373
8
Phase II study of imatinib in patients with small cell lung cancer.
2003142
9 201269
10 202358
11 202057
12 200049
13 200228
14 199724
15 200322
16 197814
17 20238
18 20236
19
The interaction of CD4 with HIV-1 gp120.
19916
20 20155

About Sandra Silberman

Sandra Silberman is a scholar working on Oncology, Hematology, Genetics, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 38 papers that have together received 6.8k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (9 papers), Cancer Treatment and Pharmacology (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Glioma Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (5 papers), Sarcoma Diagnosis and Treatment (4 papers), HIV Research and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Gastroenterology (3.5k citations), Pulmonary and Respiratory Medicine (4.0k citations), Hematology (1.1k citations), Oncology (1.8k citations) and Genetics (668 citations). Sandra Silberman has collaborated with scholars based in United States, Switzerland and Poland. Frequent co-authors include Saša Dimitrijević, George D. Demetri, Heikki Joensuu, Peter Roberts‎, Brian Druker, Christopher D.�M. Fletcher, Renaud Capdeville, Leif C. Andersson, Maarit Sarlomo‐Rikala and Pekka Tervahartiala. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Neuro-Oncology, Blood and Seminars in Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact